Search Results 361-370 of 17173 for egfr

  1. Aurinia Renal Response in Active Lupus With Voclosporin - Mayo Clinic

    Estimated glomerular filtration rate (eGFR) of ≤45 mL/minute at screening. Current or medical history of: Congenital or acquired immunodeficiency. In the ...

  2. Safety Study of SEA-CD40 in Cancer Patients - Mayo Clinic

    Estimated glomerular filtration rate (eGFR) ≥30 mL/min/1.73 m2 or ≤1.5 x ... Patient with EGFR or ALK genomic tumor aberrations should have disease ...

  3. A study to test whether survodutide helps people with a liver disease called NASH/MASH who have cirrhosis - Mayo Clinic

    Impaired renal function, defined as estimated glomerular filtration rate (eGFR) 2x ULN as measured by the central laboratory at screening. Trial ...

  4. Atrial fibrillation - Doctors and departments - Mayo Clinic

    A fast, pounding heartbeat could be due to AFib, a type of heart rhythm problem. Know the warning signs and when treatment is needed.

  5. VX15/2503 in Combination With Avelumab in Advanced Non-small Cell Lung Cancer - Mayo Clinic

    Tumors lack activating epidermal growth factor receptor (EGFR) mutations or ALK rearrangement (no EGFR or ALK testing is required if a subject has a KRAS ...

  6. Naloxegol in Treating Patients With Stage IIIB-IV Non-small Cell Lung Cancer - Mayo Clinic

    No known presence of known EGFR or EML4-ALK driver mutations in the tumor. Started first-line systemic therapy of the investigator's choice within 12 weeks ...

  7. AMZ002 Compared to Vigabatrin - Mayo Clinic

    Patient has normal renal function as defined by an estimated glomerular filtration rate (eGFR). > 60 mL/min/1.73 m^2, calculated as eGFR = 0.413 x (height ...

  8. Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab Versus Pembrolizumab Alone in Metastatic Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥ 50% (MK-2870-007) - Mayo Clinic

    * Confirmation that epidermal growth factor receptor- (EGFR-), anaplastic lymphoma kinase- (ALK-), or proto-oncogene tyrosine-protein kinase ROS (ROS1 ...

  9. Cancer Clinical Trials - Medical Professionals

    ... (eGFR ≥ 60ml/min). Dose Escalation Study of mRNA-2752 for Intratumoral Injection to Participants in Advanced Malignancies. Scottsdale/Phoenix, Ariz. The ...

  10. Ph1b/2 Dose-Escalation Study of Entinostat With Pembrolizumab in NSCLC With Expansion Cohorts in NSCLC, Melanoma, and Colorectal Cancer - Mayo Clinic

    ... (EGFR) mutations, with results available for collection in this study, and, if positive, has been treated with prior EGFR or ALK therapy. Received at least 1 ...